Detalhe da pesquisa
1.
Oral Vaccination Protects Against Severe Acute Respiratory Syndrome Coronavirus 2 in a Syrian Hamster Challenge Model.
J Infect Dis
; 225(1): 34-41, 2022 01 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-34758086
2.
Production and Clinical Evaluation of Norwalk GI.1 Virus Lot 001-09NV in Norovirus Vaccine Development.
J Infect Dis
; 221(6): 919-926, 2020 03 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31628848
3.
A Next-Generation Adenoviral Vaccine Elicits Mucosal and Systemic Immunogenicity and Reduces Viral Shedding after SARS-CoV-2 Challenge in Nonhuman Primates.
Vaccines (Basel)
; 12(2)2024 Jan 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-38400116
4.
An easy pill to swallow: oral recombinant vaccines for the 21st century.
Curr Opin Immunol
; 84: 102374, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37562075
5.
Mucosal immunization with Ad5-based vaccines protects Syrian hamsters from challenge with omicron and delta variants of SARS-CoV-2.
Front Immunol
; 14: 1086035, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36911687
6.
Design and validation of an exposure system for efficient inter-animal SARS-CoV-2 airborne transmission in Syrian hamsters.
Microbiol Spectr
; 11(6): e0471722, 2023 Dec 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37882564
7.
Drop the Needle; A Temperature Stable Oral Tablet Vaccine Is Protective against Respiratory Viral Pathogens.
Vaccines (Basel)
; 10(4)2022 Apr 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-35455342
8.
Adenovirus type 5 SARS-CoV-2 vaccines delivered orally or intranasally reduced disease severity and transmission in a hamster model.
Sci Transl Med
; 14(658): eabn6868, 2022 08 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-35511920
9.
Human influenza virus challenge identifies cellular correlates of protection for oral vaccination.
Cell Host Microbe
; 29(12): 1828-1837.e5, 2021 12 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34784508
10.
Modeling human adaptive immune responses with tonsil organoids.
Nat Med
; 27(1): 125-135, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33432170
11.
Efficacy, immunogenicity, and safety of an oral influenza vaccine: a placebo-controlled and active-controlled phase 2 human challenge study.
Lancet Infect Dis
; 20(4): 435-444, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-31978354
12.
An adjuvanted adenovirus 5-based vaccine elicits neutralizing antibodies and protects mice against chikungunya virus-induced footpad swelling.
Vaccine
; 37(24): 3146-3150, 2019 05 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-31047675
13.
Orally administered adenoviral-based vaccine induces respiratory mucosal memory and protection against RSV infection in cotton rats.
Vaccine
; 36(29): 4265-4277, 2018 07 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29895499
14.
Safety and immunogenicity of an oral tablet norovirus vaccine, a phase I randomized, placebo-controlled trial.
JCI Insight
; 3(13)2018 07 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-29997294
15.
Oral Modeling of an Adenovirus-Based Quadrivalent Influenza Vaccine in Ferrets and Mice.
Infect Dis Ther
; 5(2): 165-83, 2016 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-27071663
16.
Systemic and mucosal immune responses following oral adenoviral delivery of influenza vaccine to the human intestine by radio controlled capsule.
Sci Rep
; 6: 37295, 2016 11 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-27881837
17.
High titre neutralising antibodies to influenza after oral tablet immunisation: a phase 1, randomised, placebo-controlled trial.
Lancet Infect Dis
; 15(9): 1041-1048, 2015 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-26333337
18.
An adenovirus-based vaccine with a double-stranded RNA adjuvant protects mice and ferrets against H5N1 avian influenza in oral delivery models.
Clin Vaccine Immunol
; 20(1): 85-94, 2013 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-23155123
19.
Oral administration of an adenovirus vector encoding both an avian influenza A hemagglutinin and a TLR3 ligand induces antigen specific granzyme B and IFN-γ T cell responses in humans.
Vaccine
; 31(13): 1752-8, 2013 Mar 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-23357198
20.
Oral adenoviral-based vaccines: historical perspective and future opportunity.
Expert Rev Vaccines
; 7(1): 25-31, 2008 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-18251691